Cite
HARVARD Citation
Dunkel, I. et al. (n.d.). IMMU-08. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908. Neuro-oncology. pp. i82-i83. [Online].